PA
EBS icon

Parallel Advisors’s Emergent Biosolutions EBS Stock Holding History

Parallel Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62
Closed -$149 – 3331
2023
Q4 		$149 Hold
62
– – ﹤0.01% 3200
2023
Q3 		$211 Sell
62
-33
-35% -$183 ﹤0.01% 3222
2023
Q2 		$698 Buy
95
+18
+23% +$167 ﹤0.01% 3023
2023
Q1 		$798 Hold
77
– – ﹤0.01% 3007
2022
Q4 		$909 Buy
77
+15
+24% +$232 ﹤0.01% 2921
2022
Q3 		$1K Buy
62
+35
+130% +$974 ﹤0.01% 2887
2022
Q2 		$1K Sell
27
-22
-45% -$751 ﹤0.01% 2744
2022
Q1 		$2K Sell
49
-153
-76% -$6.75K ﹤0.01% 2560
2021
Q4 		$9K Buy
202
+176
+677% +$7.96K ﹤0.01% 2147
2021
Q3 		$1K Sell
26
-24
-48% -$1.45K ﹤0.01% 2843
2021
Q2 		$3K Buy
50
+45
+900% +$2.89K ﹤0.01% 2447
2021
Q1 		$0 Sell
5
-16
-76% -$1.64K ﹤0.01% 2817
2020
Q4 		$2K Buy
+21
New +$1.93K ﹤0.01% 2293
2020
Q3 		– Sell
-10
Closed – – 2579
2020
Q2 		$0 Buy
+10
New +$745 ﹤0.01% 2504
2020
Q1 		– Sell
-114
Closed -$6K – 2435
2019
Q4 		$6K Hold
114
– – ﹤0.01% 1901
2019
Q3 		$6K Sell
114
-114
-50% -$5.31K ﹤0.01% 1850
2019
Q2 		$11K Hold
228
– – ﹤0.01% 1546
2019
Q1 		$12K Hold
228
– – ﹤0.01% 1442
2018
Q4 		$13K Sell
228
-6
-3% -$387 ﹤0.01% 1214
2018
Q3 		$15K Buy
+234
New +$13.7K ﹤0.01% 1263

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Parallel Advisors's EBS Position: Q1 2024 in Review

Parallel Advisors sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 62 shares — an estimated $149 sold.

Parallel Advisors first reported a position in EBS in Q3 2018 and held it in 20 quarters. The position peaked at $15K in Q3 2018. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Parallel Advisors reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Parallel Advisors sold 62 Emergent Biosolutions shares in Q1 2024, an estimated $149.
  • Parallel Advisors first reported a position in Emergent Biosolutions in Q3 2018 and held it in 20 quarters.
  • Parallel Advisors's Emergent Biosolutions position peaked at $15K in Q3 2018.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.